Skip to main content

Table 3 Health-related quality-of-life (QoL) values

From: Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis

Utility or disutility

Mean

References

Uncomplicated type 2 diabetes

0.8140

[29]

Myocardial infarction

0.7360

[29]

Disutility post-myocardial infarction event

− 0.1290

[29]

Angina

0.6828

[29]

Congestive heart failure

0.6330

[29]

Stroke

0.5450

[29]

Disutility post-stroke event

− 0.2610

[29]

Peripheral vascular disease

0.5700

[30]

Microalbuminuria

0.8140

[29]

Gross proteinuria

0.8140

[29]

Haemodialysis

0.6040

[31]

Peritoneal dialysis

0.6128

[31]

Renal transplant

0.7500

[30]

Background diabetic retinopathy

0.7900

[32]

Proliferative diabetic retinopathy

0.7900

[32]

Macular oedema

0.7900

[32]

Severe vision loss

0.6700

[33]

Cataracts

0.6280

[34]

Diabetic neuropathy

0.6300

[33]

Healed ulcer (no data; assumed same as uncomplicated T2DM)

0.8140

[29]

Active ulcer

0.7500

[35]

Lower limb amputation

0.4028

[29]

Disutility post-amputation

− 0.5380

[29]

Disutility for daytime non-severe hypoglycaemic event

− 0.0050

[36]

Disutility for nocturnal non-severe hypoglycaemic event

− 0.0070

[36]

Disutility for daytime severe hypoglycaemic event not requiring medical assistance

− 0.0263

[37]

Disutility for nocturnal severe hypoglycaemic event not requiring medical assistance

− 0.0263

[37]

Disutility for daytime severe hypoglycaemic event requiring medical assistance

− 0.0550

[36]

Disutility for nocturnal severe hypoglycaemic event requiring medical assistance

− 0.0570

[36]